Register entry
BAUSCH HEALTH AMERICAS INC
- Registered sites
- 0
- Drug products
- 0
- Live patents
- 44
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
44Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| ACANYA | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | Jun 2029 |
| ACANYA | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | Aug 2029 |
| BRYHALI | HALOBETASOL PROPIONATE | Nov 2031 |
| DUOBRII | HALOBETASOL PROPIONATE; TAZAROTENE | Nov 2031 |
| DUOBRII | HALOBETASOL PROPIONATE; TAZAROTENE | Jun 2036 |
| JUBLIA | EFINACONAZOLE | Jan 2028 |
| JUBLIA | EFINACONAZOLE | Jul 2030 |
| JUBLIA | EFINACONAZOLE | Oct 2030 |
| JUBLIA | EFINACONAZOLE | Oct 2034 |
| JUBLIA | EFINACONAZOLE | Apr 2035 |
| ONEXTON | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | Jun 2029 |
| ONEXTON | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | Aug 2029 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.